I agree that this site is using cookies. You can find further informations here.
X
Voutsas, Ioannis F
49  results:
Search for persons X
?
1

Frequencies of an Immunogenic HER-2/neu Epitope of CD8+ T L..:

Goulielmaki, Maria ; Stokidis, Savvas ; Anagnostou, Theodoros...
International Journal of Molecular Sciences.  24 (2023)  6 - p. 5954 , 2023
Link: https://doi.org/10.3390/..
 
?
2

Editorial: Acute leukemias: molecular characterization, leu..:

Dancik, Garrett M. ; Varisli, Lokman ; Voutsas, Ioannis F..
Frontiers in Oncology.  13 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
3

Lower RNA expression of ALDH1A1 distinguishes the favorable..:

Dancik, Garrett M. ; Voutsas, Ioannis F. ; Vlahopoulos, Spiros
Molecular Biology Reports.  49 (2022)  4 - p. 3321-3331 , 2022
Link: https://doi.org/10.1007/..
 
?
4

T-Cell Repertoire in Tumor Radiation: The Emerging Frontier..:

Baxevanis, Constantin N. ; Gritzapis, Angelos D. ; Voutsas, Ioannis F....
Cancers.  14 (2022)  11 - p. 2674 , 2022
Link: https://doi.org/10.3390/..
 
?
5

Immune profiling of melanoma tumors reflecting aggressivene..:

Fortis, Sotirios P. ; Mahaira, Louisa G. ; Anastasopoulou, Eleftheria A....
Cancer Immunology, Immunotherapy.  66 (2017)  12 - p. 1631-1642 , 2017
Link: https://doi.org/10.1007/..
 
?
6

Further Insight into AE37 Peptide Vaccination in Prostate C..:

Anastasopoulou, Eleftheria A ; Voutsas, Ioannis F
Future Science OA.  3 (2017)  3 - p. , 2017
Link: https://doi.org/10.4155/..
 
?
7

A flow cytometric approach for studying alterations in the ..:

Papaioannou, Nikos E. ; Voutsas, Ioannis F. ; Samara, Pinelopi.
Cellular Immunology.  302 (2016)  - p. 32-40 , 2016
Link: https://doi.org/10.1016/..
 
?
8

A pilot study in prostate cancer patients treated with the ..:

Anastasopoulou, Eleftheria A. ; Voutsas, Ioannis F. ; Keramitsoglou, Theodora...
Cancer Immunology, Immunotherapy.  64 (2015)  9 - p. 1123-1136 , 2015
Link: https://doi.org/10.1007/..
 
?
9

Ovarian malignant ascites-derived lymphocytes stimulated wi..:

Voutsas, Ioannis F. ; Pistamaltzian, Nikolaos ; Tsiatas, Marinos L....
European Journal of Cancer.  49 (2013)  7 - p. 1706-1714 , 2013
Link: https://doi.org/10.1016/..
 
?
10

Ontak reduces the immunosuppressive tumor environment and e..:

Gritzapis, Angelos D. ; Voutsas, Ioannis F. ; Baxevanis, Constantin N.
Cancer Immunology, Immunotherapy.  61 (2011)  3 - p. 397-407 , 2011
Link: https://doi.org/10.1007/..
 
?
11

Combined treatment with Bevacizumab and standard chemothera..:

Tsavaris, Nikolaos ; Voutsas, Ioannis F. ; Kosmas, Christos..
Investigational New Drugs.  30 (2010)  1 - p. 395-402 , 2010
Link: https://doi.org/10.1007/..
 
?
12

A novel quantitative flow cytometric method for measuring g..:

Voutsas, Ioannis F. ; Gritzapis, Angelos D. ; Alexis, Michael N....
Journal of Immunological Methods.  324 (2007)  1-2 - p. 110-119 , 2007
Link: https://doi.org/10.1016/..
 
?
13

Combining immunological and molecular data to assess phylog..:

Valakos, Efstratios D. ; Kourkouli, Andriani ; Skopeliti, Margarita...
Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology.  147 (2007)  1 - p. 1-10 , 2007
Link: https://doi.org/10.1016/..
 
?
14

Induction of potent CD4+ T cell‐mediated antitumor response..:

Voutsas, Ioannis F. ; Gritzapis, Angelos D. ; Mahaira, Louisa G....
International Journal of Cancer.  121 (2007)  9 - p. 2031-2041 , 2007
Link: https://doi.org/10.1002/..
 
?
15

Ii-Key/HER-2/neu(776-90) hybrid peptides induce more effect..:

Sotiriadou, Nectaria N. ; Kallinteris, Nikoletta L. ; Gritzapis, Angelos D....
Cancer Immunology, Immunotherapy.  56 (2006)  5 - p. 601-613 , 2006
Link: https://doi.org/10.1007/..
 
1-15